3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Hodgkin Disease
10
Lymphoma
5
Neoplasms, Germ Cell and Embryonal
3
Seminoma
2
Vulvar Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Hemangioma, Capillary
1
Endodermal Sinus Tumor
1
Desmoid Tumors
1
Carcinoma, Embryonal
1
Interventions
nirogacestat
5
Specimen Handling
3
Cryosurgery
3
X-Rays
2
Phantoms, Imaging
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Blood Specimen Collection
2
trifluridine tipiracil drug combination
1
Oxaliplatin
1
Leucovorin
1
Ipilimumab
1
Imatinib Mesylate
1
High-Intensity Focused Ultrasound Ablation
1
Fluorouracil
1
Embolization, Therapeutic
1
Electrochemotherapy
1
E-7386
1
Doxorubicin
1
Cyclophosphamide
1
Cryotherapy
1
CTLA-4 Antigen
1
Bone Density
1
Bleomycin
1
Biopsy
1
Bevacizumab
1
Absorptiometry, Photon
1
4-hydroxy-N-desmethyltamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoid Tumors
×
Bleomycin
×
1 year
×
Clear all
NCT06660121
2026-05-14
ECT-DESMO
Istituto Ortopedico Rizzoli
Withdrawn